GALDERMA launches formulation with Alastin Skincare® A-LUMINATE Brightening Serum®

Galderma, the world's largest independent dermatology company, has launched ALASTIN Skincare^® A LUMINATE BRIGHTENING SERUM^®. The newest product addition to the ALASTIN Skincare lineup is designed to help reduce the appearance of surface pigmentation without any harsh, irritating ingredients.

Clinically proven, A-LUMINATE BRIGHTENING SERUM^® contains a multifaceted blend of peptides, antioxidants, and targeted ingredients to allow the skin to appear brighter and create a more even-toned, luminous complexion over time. ALASTIN's proprietary PATH-3 Technology helps to minimize the recurrence of surface pigmentation and protect against future damage with continued use. The innovative formula also works to complement in-office treatments including chemical peels, lasers, and skin brightening treatments. The elegant, lightweight, non-irritating serum is formulated without hydroquinone or retinol and is safe for long-term daily use.

"We are thrilled to add another innovative formulation to our daily skin care product portfolio with the launch of A-LUMINATE Brightening Serum™.  Pigmentation is a common skin concern that a lot of consumers face and we know it can be a long term battle to diminish the look of melasma and dark spots. The results of our clinical trial indicate that A-LUMINATE is a topical product that provides impressive results to minimize the appearance of dark spots and discoloration without irritation, and it can be used long-term as part of their normal skincare regimen." Amber Edwards, Chief Commercial Officer.